FDA Clinical Insights: A Panel Discussion

Hear from esteemed panelists Dorothy Abel (Partner at Abel and Wolf Consulting), Dr. Robert E. Lee (Former Medical Officer at the US FDA, Center for Devices and Radiologic Heath), Chris Mullin (Director, Global Strategy Services at NAMSA), and Dr. Adam E. Saltman (Principal Strategy Consultant, Clinical and Regulatory Services at NAMSA) as they delve into real-world examples of critical mistakes in bringing implantable vascular devices to market through the FDA. This session will provide valuable insights to help you avoid costly delays and navigate regulatory challenges effectively.

Key Highlights:

• In-depth panel discussion with industry experts
• Key insights into FDA clinical processes
• Strategies for successful clinical trials

*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.

NAMSA uses a third-party provider, GoToWebinar, to host NAMSA webinars. For information related to GoToWebinar’s privacy policy and utilization of information, please contact GoToWebinar directly.